Blood-Based Multiomics-Guided Detection of a Precancerous Pancreatic Tumor – MRM Proteomics

Skip to content

+1 (800) 559-9921

Shop
- Kits
  - MetaboloMetrics™ Kits
  - PeptiQuant™ Plus Kits
- Request a Quote
About Us
- Company
- Technology
Services
Bioinformatics
Products
QuaProLIMS
Workshops
News
- News
- Events
- Publications
Contact
- MRMP Europe

Blood-Based Multiomics-Guided Detection of a Precancerous Pancreatic Tumor

Share:

Post navigation

Previous PostMeasurement of CYP1A2 and CYP3A4 activity by a simplified Geneva cocktail approach in a cohort of free-living individuals: a pilot study.

Next PostA Simplified Proteomics LC-MRM-MS Assay for Determination of apoE Genotypes in Plasma Samples

Written by Sophia Borchers

What are you looking for?

Search for:

MRM Proteomics Inc. was established in 2010 as a spin-out company to commercialize the cutting-edge proteomics technologies, tools and know-how developed at the University of Victoria-Genome BC Proteomics Centre.

CONTACT

MRM Proteomics Inc.
SB-5100
141, Ave du Président-Kennedy
Montreal, QC, H2X 1Y4 Canada

Tel: +1 (800) 559-9921
Email: info@mrmproteomics.com
URL: www.mrmproteomics.com

QUICK LINKS

Company Technology Services Products News Contact

GENERAL

Terms and Conditions Shipping FAQ Privacy Policy Terms of Use Resources Calendar of Events

2019 © MRM Proteomics. All Rights Reserved | Privacy Policy